Lancet Rheumatology

Scope & Guideline

Connecting researchers to transform rheumatological practices.

Introduction

Immerse yourself in the scholarly insights of Lancet Rheumatology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2665-9913
PublisherELSEVIER
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2019 to 2024
AbbreviationLANCET RHEUMATOL / Lancet Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The Lancet Rheumatology journal focuses on advancing the understanding and treatment of rheumatic diseases through high-quality research and clinical studies. Its primary aim is to provide a platform for innovative research that can improve patient outcomes and guide clinical practice.
  1. Rheumatic Disease Research:
    The journal emphasizes research on various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome, exploring their pathophysiology, diagnosis, and management.
  2. Clinical Trials and Interventions:
    A significant focus is on clinical trials evaluating new therapies, treatment strategies, and interventions aimed at improving patient care and outcomes in rheumatology.
  3. Patient-Centered Approaches:
    The journal promotes research that incorporates patient perspectives, emphasizing the importance of patient-reported outcomes and engagement in treatment decisions.
  4. Emerging Therapies and Precision Medicine:
    A core area of interest involves exploring novel therapeutics, including biologics and targeted therapies, and their application in personalized medicine for rheumatic diseases.
  5. Public Health and Epidemiology:
    Research addressing the epidemiology of rheumatic diseases, health disparities, and the impact of socioeconomic factors on disease management is also a critical focus.
  6. COVID-19 and Autoimmunity:
    Given the recent pandemic, the journal has increasingly published studies on the intersection of COVID-19 and rheumatic diseases, including vaccine responses and management strategies.
The Lancet Rheumatology has been at the forefront of several emerging themes in rheumatology research, reflecting the evolving landscape of the field.
  1. Digital Health and Telemedicine:
    Recent publications highlight the growing integration of digital health technologies and telemedicine in managing rheumatic diseases, especially in the context of the COVID-19 pandemic.
  2. Vaccine Research in Autoimmune Diseases:
    There is a marked increase in research focused on vaccine responses among patients with autoimmune conditions, particularly regarding COVID-19 vaccinations and their implications for treatment.
  3. Health Equity and Social Determinants:
    Emerging themes include a focus on health equity, social determinants of health, and their impact on the management of rheumatic diseases, addressing disparities in care.
  4. Patient Engagement and Self-Management:
    There is a rising trend in research exploring patient engagement strategies and self-management approaches, emphasizing the importance of involving patients in their care.
  5. Precision Medicine and Biomarkers:
    The journal increasingly features studies on precision medicine, with a focus on identifying biomarkers that can guide treatment decisions and improve patient outcomes.
  6. COVID-19 Impact Studies:
    The ongoing impact of COVID-19 on rheumatology care continues to be a significant area of research, with studies evaluating the effects on disease management and patient safety.

Declining or Waning

While the journal has seen growth in certain areas, some themes have become less prominent over recent years, indicating a potential shift in research focus.
  1. Traditional Therapies:
    There has been a noticeable decline in papers focused on traditional treatments for rheumatic diseases, such as corticosteroids and non-steroidal anti-inflammatory drugs, as the field shifts towards biologics and targeted therapies.
  2. Basic Science Research:
    The journal has published fewer studies centered exclusively on basic science, such as bench research, as the emphasis moves towards translational and clinical research that directly impacts patient care.
  3. Longitudinal Studies in Established Cohorts:
    Research utilizing long-term follow-up of established cohorts has decreased, potentially as the emphasis shifts towards more immediate clinical trials and interventions.
  4. Single-Center Studies:
    There appears to be a waning interest in single-center studies, with a preference for multicenter collaborations that can provide broader insights and more robust data.

Similar Journals

Indian Journal of Rheumatology

Connecting researchers and practitioners in the realm of rheumatology.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

European Journal of Rheumatology

Fostering Collaboration for a Healthier Future
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Current Rheumatology Reviews

Exploring breakthroughs in rheumatology advancements.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Open Access Rheumatology-Research and Reviews

Unlocking the Future of Rheumatology, One Review at a Time.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Pediatric Rheumatology

Transforming pediatric rheumatology with open access knowledge.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Advancing rheumatology through impactful research.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

Current Rheumatology Reports

Pioneering insights into rheumatological diseases.
Publisher: SPRINGERISSN: 1523-3774Frequency: 12 issues/year

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

BMC Rheumatology

Advancing knowledge in rheumatology without barriers.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.

Arthritis & Rheumatology

Connecting Researchers to Transformative Discoveries
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Revista Cubana de Reumatologia

Advancing rheumatological research for a healthier future.
Publisher: SOC CUBANA REUMATOLOGIAISSN: 1606-5581Frequency: 2 issues/year

Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.